Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Jin-fang Song"'
Publikováno v:
BMC Geriatrics, Vol 23, Iss 1, Pp 1-13 (2023)
Abstract Background This study explored the impact of MTM service on MMD patients with hypertension. Methods A total of 120 MMD inpatients from September to November 2019 were received and randomly divided into intervention group and control group. G
Externí odkaz:
https://doaj.org/article/6f95504dfa1b4353a46aa3d5a0d923a7
Publikováno v:
BMC Endocrine Disorders, Vol 22, Iss 1, Pp 1-7 (2022)
Abstract Background To study the bacteriological characteristics, risk factors, and treatment of multi-drug resistance (MDR) organisms in patients with diabetic foot infection. Methods Patients with diabetic foot ulcer admitted to hospital from June
Externí odkaz:
https://doaj.org/article/de739a039bfa4fd387deb67d07576db4
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-8 (2021)
Abstract Background Genetic polymorphisms in the PPARD and NOS1AP is associated with type 2 diabetes mellitus (T2DM); however, there is no evidence about its impact on the therapeutic efficacy of nateglinide. This study was designed to investigate a
Externí odkaz:
https://doaj.org/article/f92d501db35445b38ef50844de64aaab
Autor:
Jin-Fang Song, Jie Zhang, Ming-Zhu Zhang, Jiang Ni, Tao Wang, Yi-Qing Zhao, Naveed Ullah Khan
Publikováno v:
BMC Medical Genomics, Vol 14, Iss 1, Pp 1-9 (2021)
Abstract Genetic polymorphisms in the MTNR1B gene is associated with type 2 diabetes mellitus (T2DM); however, there is no evidence about its impact on the therapeutic efficacy of nateglinide. This prospective case–control study was designed to inv
Externí odkaz:
https://doaj.org/article/29178ae890034335813d83a2ee96c358
Publikováno v:
International Journal of Diabetes in Developing Countries. 42:283-289
Comprehensive management of type 2 diabetes mellitus (T2DM) patients has a low control rate, and there is a lack of prospective studies involving clinical pharmacists in outpatient management of patients with T2DM. This study was designed to investig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7454b06fee30a62203c3fd14f8e4b1f5
https://doi.org/10.1007/s13410-021-00967-z
https://doi.org/10.1007/s13410-021-00967-z
Publikováno v:
BMC geriatrics. 23(1)
Background This study explored the impact of MTM service on MMD patients with hypertension. Methods A total of 120 MMD inpatients from September to November 2019 were received and randomly divided into intervention group and control group. General se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::10b6432d283b4460d39957471fcfced1
https://pubmed.ncbi.nlm.nih.gov/36609228
https://pubmed.ncbi.nlm.nih.gov/36609228
Publikováno v:
BMC endocrine disorders. 22(1)
Background To study the bacteriological characteristics, risk factors, and treatment of multi-drug resistance (MDR) organisms in patients with diabetic foot infection. Methods Patients with diabetic foot ulcer admitted to hospital from June 2018 to D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0d67617912273c8de60f28596c3f0587
https://pubmed.ncbi.nlm.nih.gov/35189877
https://pubmed.ncbi.nlm.nih.gov/35189877
Autor:
Jin-Fang Song, Temitope Isaac Adelusi, Wei Li, Jing Zhu, Zhenhai Shang, Qian Lu, Xiaoxing Yin, Sun Juan, Dongmei Lv, Tao Wang, Xueyan Zhou, Zejun Bao, Yan Wang
Publikováno v:
Scientific Reports
Repaglinide is an insulin secretagogue that often exhibits considerable interindividual variability in therapeutic efficacy. The current study was designed to investigate the impact of KCNQ1 genetic polymorphism on the efficacy of repaglinide and fur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c044ec1326ce8c1d992eff478b243467
https://pubmed.ncbi.nlm.nih.gov/27857189
https://pubmed.ncbi.nlm.nih.gov/27857189
Publikováno v:
Analytical Biochemistry. 304:126-129
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a147ac59edf06aebee3805ba0748d6b1
https://doi.org/10.1006/abio.2001.5589
https://doi.org/10.1006/abio.2001.5589
Autor:
Jin-Fang Song, Hao Guo, Xiaoxing Yin, Xueyan Zhou, Ya-Wen Cui, Dongmei Lv, Yan Wang, Wei Li, Dan-Dan Wang, Tao Wang, Qian Lu, Jing Zhu, Fan Zhang
Publikováno v:
Clinical and experimental pharmacologyphysiology. 42(1)
Summary Repaglinide is a short-acting insulin secretagogue, which often results in considerable interindividual variability in therapeutic efficacy when widely used in a clinical setting. Among various reasons under discussion is genetic polymorphism
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08fc9d32f17e31ac1a3f1e48a571183d
https://pubmed.ncbi.nlm.nih.gov/25311380
https://pubmed.ncbi.nlm.nih.gov/25311380